FDA Drug recall D-0252-2021
Lidocaine/Tetracaine (LIPO110)* 23%/7% Ointment 100 GMS per 4 ounce plastic ointment jar, Rx Only, Stanley Specialty Pharmacy 3120 Latrobe…
- FDA Drug
- Class II
- terminated
- Published 2021-02-17
On 2021-02-17 the FDA classified a Class II recall of Lidocaine/Tetracaine (LIPO110)* 23%/7% Ointment 100 GMS per 4 ounce plastic ointment jar, Rx Only, Stanley Specialty Pharmacy 3120 Latrobe… by Stanley Specialty Pharmacy Compounding And Wellness Center, citing superpotent Drug. Lidocaine higher concentration than listed.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0252-2021 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-01-21 |
| Published | 2021-02-17 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Stanley Specialty Pharmacy Compounding And Wellness Center |
| Distribution | US |
Product
Lidocaine/Tetracaine (LIPO110)* 23%/7% Ointment 100 GMS per 4 ounce plastic ointment jar, Rx Only, Stanley Specialty Pharmacy 3120 Latrobe Dr. Suite 200 Charlotte, NC 28211
Reason
Superpotent Drug. Lidocaine higher concentration than listed
Identifiers
| code_info | Lot: 195789 Exp. Apr. 17 2021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0252-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.